English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background: Of the numerous emerging biomarkers for coronary heart disease (CHD), lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme involved in lipid metabolism and inflammatory pathways, seems to be a promising candidate. Implementation of Lp-PLA2 measurement into clinical practice, however, requires data on the reliability of such measurements. Methods: We measured Lp-PLA2 concentrations by ELISA in blood samples drawn from 200 post–myocardial infarction patients (39–76 years) at 6 monthly intervals between May 2003 and February 2004, for a total of 1143 samples. We estimated analytical, within-individual, and between-individual variation, the critical difference, and the intraclass correlation coefficient of reliability (ICC) to assess the reliability of serial Lp-PLA2 measurements. Results: The mean (SD) plasma Lp-PLA2 concentration for the study participants was 188.7 (41.8) μg/L, with no significant difference between men and women. The analytical CV for Lp-PLA2 was 4.4%, the within-individual biological CV was 15%, and the between-individual CV was 22%. The ICC was 0.66. An important part of the total variation in plasma Lp-PLA2 concentration was explained by the between-individual variation (as a percentage of the total variance, 66.1%), whereas the within-individual variance was 31.3%. The analytical variance was as low as 2.6%. Conclusions: Between-individual variation in Lp-PLA2 concentration was substantially greater than within-individual variation. In general, our data demonstrate considerable stability and good reproducibility of serial Lp-PLA2 measurements, results that compared favorably with those for the more commonly measured lipid markers.

clinical chemistry

Variability of Serial Lipoprotein-Associated Phospholipase A2 Measurements in Post–Myocardial Infarction Patients: Results from the AIRGENE Study Center Augsburg